Fusion Protein and Hybridoma
$95,810P01FY2009CANIH
University Of Miami School Of Medicine, Coral Gables FL
Investigators
Linked publications & trials
Paper 28219835Paper 27437104Paper 26418746Paper 26402460Paper 25739764Paper 24687086Paper 24293008Paper 24248605Paper 23753625Paper 23257510Paper 23018461Paper 22956587Paper 22902792Paper 22772949Paper 22659217Paper 21984699Paper 21488890Paper 21277409Paper 21253724Paper 21182087Paper 20890040Paper 20732639Paper 20226686Paper 19924120Paper 19638986Paper 19223534Paper 19185518Paper 19016524Paper 18413768Paper 18391756Paper 17942937Paper 17935075
Abstract
The Fusion Proteins and Monoclonal Antibodies Core will design, generate and purify fusion proteins and monoclonal antibodies for the Regulation of Tumor Immunity Program. The core in a cost-effective way will provide individual projects with large amounts of monoclonal antibodies and fusion proteins needed for plate coating, large scale cell separation in vitro, and cell blocking and depletion experiments in vivo. The core will also purify required amounts of monoclonal antibodies and fusion proteins unique for the proposed research, and generate and characterize new fusion proteins and hybridomas.
View original record on NIH RePORTER →